Elecare

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Elecare

What is EleCare?

EleCare is a specialized amino acid-based nutritional formula designed for infants and children who cannot tolerate intact or hydrolyzed proteins. It is classified as an elemental formula, meaning its protein component is replaced by individual amino acids, which are the simplest building blocks of protein. This design allows for easier digestion and absorption, as it eliminates the risk of protein-induced allergic reactions.

Composition and Function

The formula is primarily used to provide complete nutrition for those with severe food allergies or gastrointestinal conditions. Its composition typically includes:

  • Amino Acids: Non-allergenic protein sources that do not trigger an immune response.
  • Carbohydrates: Often derived from corn syrup solids to provide energy.
  • Fats: A blend of oils, often including medium-chain triglycerides (MCTs), which are more easily absorbed by individuals with fat malabsorption issues.
  • Vitamins and Minerals: Essential nutrients required for growth and development in pediatric populations.

Common Uses

EleCare is used in the management of several clinical conditions where standard or hypoallergenic formulas are ineffective. These include:

  • Severe Food Allergies: Particularly for those with multiple food protein allergies or a severe allergy to cow's milk.
  • Eosinophilic Gastrointestinal Disorders: Such as eosinophilic esophagitis (EoE), where specific proteins cause inflammation in the digestive tract.
  • Malabsorption Syndromes: Conditions where the gut is unable to process complex nutrients effectively, such as short bowel syndrome.
  • Gastrointestinal Impairment: Other conditions requiring a highly digestible, elemental diet to maintain nutritional status.

What side effects are possible with Elecare?

Possible Side Effects and Safety Information

The official safety profile for Elecare, an elemental formula, is structured around two categories of officially documented risks: potential severe allergic responses and public health safety alerts regarding microbial contamination. No adverse reactions are formally classified as Common in regulatory summaries; the focus is on serious, low-frequency events.

Officially Documented Safety Concerns

The most serious risks identified in regulatory documents are related to potential Systemic Hypersensitivity Reactions, which are categorized under Immune System Disorders. These include symptoms of severe allergic response such as difficulty breathing, swelling of the face, or chest tightness. Additionally, the regulatory profile includes warnings regarding the risk of Serious Bacterial Infections—specifically Cronobacter sakazakii and Salmonella Newport—linked to powdered formula, which are classified under Infections and Infestations and can lead to outcomes like Sepsis or Meningitis.

Safety Restrictions and Vulnerable Populations

Official labeling contains specific Safety Restrictions, including the explicit prohibition of Intravenous (IV) use. Furthermore, caution is advised regarding the concurrent use of large doses of other vitamins to prevent nutrient imbalance, as the formula provides complete nutrition. Safety notes are included for Vulnerable Populations: because powdered formulas are not sterile, they should only be fed to Premature or Immunocompromised Infants under medical supervision. The formula is contraindicated in individuals with a known allergy to any of its ingredients.

Overdose and Emergency Response

Elecare Overdose and when to seek help

As a specialized elemental formula (medical food), the official regulatory guidance for EleCare defines its emergency profile based on severe acute safety events that mandate urgent intervention, rather than a toxicological overdose profile from excessive nutritional intake. Immediate medical attention is required for specific documented manifestations.

Documented Emergency Manifestations and Outcomes

Emergency warnings are issued for two primary categories of severe events. Manifestations of a severe acute reaction include swelling of the face, difficulty breathing, tightness in the chest, and rash. Symptoms of a serious systemic infection include fever, poor feeding, excessive crying, lethargy, jaundice, and blood in the stool. Both symptom clusters require urgent response.

Serious outcomes include life-threatening risks associated with severe illness from potentially compromised product batches. Regulatory investigations have noted reported fatalities linked to these severe systemic infections. All emergency warnings are specific to the infant and child population who rely on the product.

Required Emergency Actions

Official guidance explicitly states that if any signs of a severe allergic reaction are present, users must seek immediate medical attention right away. If an infant exhibits systemic infection symptoms (fever, poor feeding), caregivers must contact a health care provider immediately to report symptoms and ensure prompt medical care. No specific pharmacological antidote is known or applicable; management is symptomatic and supportive.

Therapeutic Uses of Elecare

What EleCare Treats: Main Uses and Benefits

EleCare is an amino acid-based medical food designed to provide complete nutritional support for patients with conditions that require an elemental diet. The specialized formulation is intended for use when a person cannot tolerate intact proteins or extensively hydrolyzed proteins found in other formulas.

The nutritional support provided by this formula helps manage the complex dietary needs of several conditions, including severe cow's milk protein allergy, eosinophilic gastrointestinal disorders (EGID), short bowel syndrome, and malabsorption syndromes. Using EleCare assists in the nutritional planning for these diagnoses by supplying easily absorbed nutrients while helping to minimize the risk of encountering common allergic triggers.

This specialized formulation can be an important component of the nutritional care plan for patients with severe protein sensitivities.

Relief for Severe Allergic Symptoms

Regulatory References

  1. NIH MedlinePlus Cow Milk Allergy guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Elecare?

Elecare is a specialized amino acid-based medical food, and its eligibility for use is strictly defined by regulatory documents based on medical necessity and age.

Eligibility Scope

The product is authorized primarily for patients who require an elemental diet due to intolerance to intact or extensively hydrolyzed protein. This defines eligibility for infants (0–12 months) and children (1 year and older) with conditions such as severe food allergies or malabsorption syndromes.

Populations Contraindicated and Restricted

Elecare is contraindicated for any patient with a known allergy or hypersensitivity to any ingredient in the formulation. Use is strictly limited to oral or tube feeding; it is Not for IV Use. Furthermore, the use of powdered Elecare in premature infants or those with immune problems is restricted and requires explicit direction and supervision by a doctor due to the formula's non-sterile nature.

Special Use Considerations

For adult patients using the junior formulation, eligibility is conditional: pregnant or breastfeeding patients must discuss the benefits and risks with a healthcare provider. Patients with diabetes are advised to monitor blood sugar levels closely during use.

What should I know about interactions with other medicines?

Interactions with other medicines and products — official regulatory information for EleCare

The interaction profile for EleCare, an elemental formula, is defined by its nutritional composition rather than by typical drug-metabolism pathways. Official regulatory information states that no specific interactions are known for the majority of medicinal products.

Documented Interaction Scope

Category Official Regulatory Statement
Interacting Substances Levodopa, Tetracyclines, Bisphosphonates, and large doses of other vitamins/minerals.
Interaction Mechanism Chelation: Binding of other substances by Polyvalent Cations (Iron, Calcium) in the formula.
Outcome Classification Exposure-Modifying Interaction (Reduced systemic absorption of the co-administered drug).
Timing Requirement Mandatory separation of administration is required for Levodopa, Tetracyclines, and Bisphosphonates to mitigate reduced drug exposure.

Official Regulatory Cautions

  • The formula's Iron Salts and Polyvalent Cations can reduce the systemic exposure of certain oral medications, such as Levodopa, requiring administration timing rules.
  • A restriction is documented against concurrently taking large doses of other vitamins due to concerns about cumulative nutritional load.
  • A specific physiological caution is noted for diabetic patients: some EleCare brands may affect blood sugar levels and necessitate close monitoring.

Summary of Interaction Profile:

Official regulatory documents define the EleCare interaction structure by its physical properties as a mineral-containing elemental formula. The profile is limited to chelation-based reductions in the exposure of specific oral medications, managed through required administration timing rules, alongside a caution related to blood glucose effects.

Mechanism of Action

Immunological Antigen Exclusion

The mechanism of EleCare is fundamentally one of antigen avoidance. By providing the nitrogen source as 100% free L-amino acids, the formula lacks the complex peptide structures required for immune recognition by intestinal receptors. This preemptive structural action halts the Type I and Type IV hypersensitivity cascades, preventing the release of inflammatory mediators and promoting the re-establishment of the intestinal barrier integrity via reduction of chronic immunological activation.

Digestive Bypassing and Optimized Absorption

This elemental composition eliminates the need for extensive luminal digestion by proteases, thereby reducing the systemic and local energetic burden associated with complex protein hydrolysis. The small molecular size of the amino acids facilitates their rapid and direct passive absorption across the epithelial lining. This optimized assimilation pathway facilitates the uptake of essential substrates required for intrinsic cellular synthesis and maintenance, limiting the osmotic changes associated with incomplete protein hydrolysis and subsequent fermentative processes.

Dosage and Administration Information

EleCare is a medical food used as a primary source of complete nutrition, with usage instructions focused on accurate preparation and strict administration protocols. The formula is intended for oral administration or tube feeding (enteral use) and is explicitly designated as Not for intravenous use.

Administration Scope and Dosing

The product is available in age-specific formulations: EleCare is for infants from 0 to 12 months and EleCare Jr for children aged 1 year and older. The formula does not adhere to a fixed pharmacological dose; instead, the dosing regimen is highly individualized and determined by a healthcare professional to meet the specific caloric and nutritional needs of the patient.

Preparation and Procedural Constraints

Proper use requires reconstituting the powder with water according to physician instructions. The standard preparation for infant formula involves mixing one level scoop of powder with two fluid ounces of water to achieve the typical 20 Cal/fl oz dilution. Accurate measurement is critical and requires the measuring scoop provided or a scale that reads in grams. Preparation must always be performed under medical supervision.

Administration is governed by strict timing rules. Once prepared, the formula must be stored under refrigeration and used within 24 hours. Any prepared formula remaining after a feeding has commenced must be discarded within one hour. It is also explicitly instructed that prepared formula should never be warmed using a microwave oven.

Recent Clinical Evidence

Recent Clinical Evidence

EleCare is an amino acid-based formula (AAF) indicated for infants and children with severe food allergies, such as cow's milk protein allergy (CMPA), intolerance to extensively hydrolyzed formulas, or other gastrointestinal (GI) conditions where an elemental diet is required. Clinical research focuses primarily on its hypoallergenicity and ability to support normal growth.

Efficacy and Symptom Management

Studies examining AAFs, including formulations similar to EleCare, have investigated their role in managing allergic and GI symptoms. Research has explored the following associations:

  • Symptom Improvement: Evidence suggests that AAFs are used for infants whose symptoms of suspected CMPA—including gastrointestinal, skin, and respiratory manifestations—do not improve adequately with extensively hydrolyzed formulas. Research has noted improvement in these symptom profiles after initiation of an AAF.
  • Protein Tolerance: As an elemental formula, its nitrogen source is 100% free amino acids, the basic building blocks of protein. This composition virtually eliminates the potential for an allergic reaction triggered by intact or partially hydrolyzed proteins, supporting its use in cases of severe or multiple food allergies.

Growth and Nutritional Support

EleCare is designed to be nutritionally complete when used as a primary source of nutrition. Clinical studies have shown that when this formula is provided as the exclusive source of nutrition, it is associated with normal growth and development in infants and children with food allergies or GI conditions. This includes supporting appropriate weight, length, and head circumference measures comparable to established growth standards.

Key Studies & References

  1. Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow's Milk Protein Allergy
  2. Short-term symptom improvement in infants with suspected cow's milk protein allergy using amino acid formula: a prospective cohort analysis
  3. The use of amino acid formulas in pediatric patients with allergy to cow's milk proteins: Recommendations from a group of experts

Frequently Asked Questions (FAQ)

Common questions about Elecare (FAQ)


Q: What regulatory information addresses the manufacturing quality of Elecare?

Regulatory agencies, such as the FDA, enforce strict quality and safety standards for the production of specialized formulas. This oversight addresses the inherent safety risks associated with powdered formulas, including the potential for Serious Bacterial Infections (like Cronobacter sakazakii), and reflects regulatory oversight through facility inspections and safety alerts.


Q: Does the use of Elecare affect blood tests or other medical monitoring?

Official cautionary information notes that some versions of EleCare may affect blood sugar levels in patients with diabetes, which may be a factor requiring close monitoring. The formula's mineral content is a consideration because it may influence the absorption of certain medications that are managed using blood tests.


Q: What is the general expectation for weight gain or growth while using Elecare?

Studies and official information indicate that EleCare is associated with supporting normal growth and development when it is used as the primary source of nutrition. It is associated with providing measures for weight, length, and head circumference that are consistent with established growth standards.


Q: Is Elecare used in hospital settings for nutrition support?

Yes, EleCare's official product information describes its use via tube feeding (enteral administration). Furthermore, its use in premature or immunocompromised infants is restricted, requiring explicit medical supervision, which is consistent with use in clinical settings.


Q: Are there different versions of Elecare available?

According to official documentation, EleCare is available in different versions tailored to patient age. This includes EleCare for infants (0–12 months) and EleCare Jr for children (1 year and older). There are also variations that include specific nutrients like DHA and ARA.


Q: Why do official documents mention Elecare is for 'nutritional management'?

Official product materials classify EleCare as a specialized medical food. This means its primary function is the nutritional management of patients who have specific medical conditions, such as severe food intolerances or gastrointestinal disorders, that prevent them from tolerating a standard diet.


Q: Can Elecare cause a reaction if someone has an allergy to corn?

Official ingredient lists state that the formula contains Corn Syrup Solids as a major component. The product is officially contraindicated for any patient with a known allergy or hypersensitivity to any ingredient listed in the formulation.


Q: Are there known interactions between Elecare and common over-the-counter supplements?

Official regulatory cautions advise a restriction against concurrently administering large doses of other vitamins or minerals. This is due to the potential for nutrient overload, as the formula itself is designed to provide complete nutrition. This caution is generally extended to all supplemental intakes that might result in a cumulative nutritional load.


Q: If Elecare is used, does it replace all other forms of nutrition?

Official documentation describes EleCare as a nutritionally complete product. It is intended to be used as a primary source of complete nutrition or, for patients with severe intolerance, as the sole source of nutrition as determined by the patient's individual nutritional plan.


Q: Why is Elecare typically only available through a prescription or recommendation?

EleCare is classified as a specialized medical food (medically necessary formula). Regulatory documents require the product to be used under medical supervision because its specialized nature and individualized dosing are essential for managing severe medical conditions.


Q: Are there common questions related to Elecare's use during travel?

Official Storage and Handling instructions must be followed regardless of location. Unopened powder is stored at room temperature, but once prepared, the liquid formula must be immediately refrigerated and used within 24 hours, as proper storage is necessary to support product safety and quality.


Q: How is the term 'failure to thrive' related to the typical use of Elecare?

EleCare is indicated for the nutritional management of conditions, such as malabsorption or severe food allergies. These underlying issues are common causes of Organic Failure to Thrive (FTT), making EleCare a key specialized nutritional intervention in this clinical context.


Q: Are there considerations for people who have kidney issues when using Elecare?

Yes, the official nutritional data includes the formula's Potential Renal Solute Load (PRSL), alongside its protein and mineral content. This specific information is required by healthcare providers to manage patients with kidney issues who need careful solute and fluid balance control.


Q: Do official materials specify Elecare's use in individuals with digestive disorders?

Official product indications specify EleCare's role in the dietary management of various gastrointestinal disorders. These include conditions like malabsorption, Chronic Diarrhea, Eosinophilic GI Disorders (EGID), and Food Protein-Induced Enterocolitis Syndrome (FPIES).


Q: Can Elecare be used as a supplement alongside a regular diet?

Official information emphasizes its function as a primary or sole source of complete nutrition. There is an official caution against administering large doses of other vitamins. This information suggests that using it as a general supplement alongside a full, unmonitored diet is not its primary intended use as defined by official labeling.


Q: In what forms (powder, liquid) is Elecare generally described as being available?

The product is described in official materials as a powdered formula that requires reconstitution with water according to specific directions. Once prepared, it becomes a liquid feed suitable for oral consumption or administration via a feeding tube.

How should Elecare be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal instructions for EleCare powder vary depending on whether the product is in its dry state or prepared as a liquid formula. All requirements are based on official regulatory labeling to ensure product quality and hygienic handling.

Product State Storage Condition Stability/Use-By Limit
Unopened/Opened Powder Store at room temperature and avoid extreme heat. Keep container tightly closed. Use opened container contents within one month.
Prepared Liquid Formula Store immediately in the refrigerator. Do not freeze. Must be used within 24 hours of refrigeration.

Prepared formula must be discarded if it has been refrigerated for more than 24 hours or if it remains unused one hour after a feeding has begun. Improper storage and handling could result in severe harm, emphasizing the need to carefully follow all instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Elecare found in:

A-Z Index: